BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 944046 NC(=O)c1ccc2C[C@@H]3C4CCC(=O)C[C@]4(CCN3CC3CC3)c2c1 InChI=1S/C21H26N2O2/c22-20(25)15-4-3-14-10-19-17-6-5-16(24)11-21(17,18(14)9-15)7-8-23(19)12-13-1-2-13/h3-4,9,13,17,19H,1-2,5-8,10-12H2,(H2,22,25)/t17?,19-,21+/m1/s1 YYCPDDHWNLMNEK-FMVHKLRBSA-N 457874 US10752592, Compound B Mu-type opioid receptor Homo sapiens 0.083 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457874&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862205 441289152 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944047 NC(=O)c1ccc2C[C@@H]3C4CCC(=O)C[C@]4(CCN3CC3CC3)c2c1 InChI=1S/C21H26N2O2/c22-20(25)15-4-3-14-10-19-17-6-5-16(24)11-21(17,18(14)9-15)7-8-23(19)12-13-1-2-13/h3-4,9,13,17,19H,1-2,5-8,10-12H2,(H2,22,25)/t17?,19-,21+/m1/s1 YYCPDDHWNLMNEK-FMVHKLRBSA-N 457874 US10752592, Compound B Mu-type opioid receptor Homo sapiens 0.980 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457874&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862205 441289152 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944048 NC(=O)c1ccc2C[C@@H]3C4CCC(=O)C[C@]4(CCN3CC3CC3)c2c1 InChI=1S/C21H26N2O2/c22-20(25)15-4-3-14-10-19-17-6-5-16(24)11-21(17,18(14)9-15)7-8-23(19)12-13-1-2-13/h3-4,9,13,17,19H,1-2,5-8,10-12H2,(H2,22,25)/t17?,19-,21+/m1/s1 YYCPDDHWNLMNEK-FMVHKLRBSA-N 457874 US10752592, Compound B Mu-type opioid receptor Homo sapiens 2.00 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457874&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862205 441289152 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944049 CN1CC[C@]23[C@@H]4Oc5c2c(C[C@H]1[C@H]3C=C[C@H]4O)ccc5O InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m1/s1 BQJCRHHNABKAKU-QHQPWPDESA-N 224017 (+)-Morphine::US10752592, Compound morphine::US10836728, Compound Morphine::US11534436, Compound morphine Mu-type opioid receptor Homo sapiens 0.320 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=224017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=224017&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 5479215 336291654 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944050 CN1CC[C@]23[C@@H]4Oc5c2c(C[C@H]1[C@H]3C=C[C@H]4O)ccc5O InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m1/s1 BQJCRHHNABKAKU-QHQPWPDESA-N 224017 (+)-Morphine::US10752592, Compound morphine::US10836728, Compound Morphine::US11534436, Compound morphine Mu-type opioid receptor Homo sapiens 34.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=224017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=224017&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 5479215 336291654 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944051 O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19?,20-,21+/m0/s1 NETZHAKZCGBWSS-XDWDPSITSA-N 179908 US10736890, Compound TABLE B.1::US10752592, Compound nalbuphine::US11534436, Compound nalbuphine::US9133125, Table D, nalbuphine Mu-type opioid receptor Homo sapiens 1.30 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179908&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 5360630 313084732 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944052 O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19?,20-,21+/m0/s1 NETZHAKZCGBWSS-XDWDPSITSA-N 179908 US10736890, Compound TABLE B.1::US10752592, Compound nalbuphine::US11534436, Compound nalbuphine::US9133125, Table D, nalbuphine Mu-type opioid receptor Homo sapiens 21.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179908&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 5360630 313084732 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944053 O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC1CCC1)c45 InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19?,20-,21+/m0/s1 NETZHAKZCGBWSS-XDWDPSITSA-N 179908 US10736890, Compound TABLE B.1::US10752592, Compound nalbuphine::US11534436, Compound nalbuphine::US9133125, Table D, nalbuphine Mu-type opioid receptor Homo sapiens 88.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179908&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 5360630 313084732 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944054 CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5O[C@@H]2[C@]3(CCN1CC1CC1)c45 InChI=1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29+/m1/s1 RMRJXGBAOAMLHD-CTAPUXPBSA-N 50354578 BUPRENORPHINE::US10752592, Compound buprenorphine::US11534436, Compound buprenorphine::US9315514, Buprenorphine Mu-type opioid receptor Homo sapiens 0.410 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50354578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50354578&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 9848990 136361264 C08007 ZINC38321402 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944055 CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5O[C@@H]2[C@]3(CCN1CC1CC1)c45 InChI=1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29+/m1/s1 RMRJXGBAOAMLHD-CTAPUXPBSA-N 50354578 BUPRENORPHINE::US10752592, Compound buprenorphine::US11534436, Compound buprenorphine::US9315514, Buprenorphine Mu-type opioid receptor Homo sapiens 0.300 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50354578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50354578&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 9848990 136361264 C08007 ZINC38321402 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944056 CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5O[C@@H]2[C@]3(CCN1CC1CC1)c45 InChI=1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29+/m1/s1 RMRJXGBAOAMLHD-CTAPUXPBSA-N 50354578 BUPRENORPHINE::US10752592, Compound buprenorphine::US11534436, Compound buprenorphine::US9315514, Buprenorphine Mu-type opioid receptor Homo sapiens 0.450 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50354578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50354578&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 9848990 136361264 C08007 ZINC38321402 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944057 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1O InChI=1S/C22H30N2O3/c23-20(26)16-7-6-15-12-17-22(27)9-2-1-8-21(22,18(15)19(16)25)10-11-24(17)13-14-4-3-5-14/h6-7,14,17,25,27H,1-5,8-13H2,(H2,23,26)/t17-,21+,22-/m1/s1 SIJATVAZXUYZQN-VOQZNFBZSA-N 179873 US10231963, Table B.17::US10287250, Compound B.1::US10736890, Compound TABLE B.17::US10752592, Compound TABLE B.1::US11534436, Compound Table B.17::US9133125, Table B, Compound 1::US9656961, Example 00134 Mu-type opioid receptor Homo sapiens 0.280 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179873&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 56847097 313084701 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944058 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1O InChI=1S/C22H30N2O3/c23-20(26)16-7-6-15-12-17-22(27)9-2-1-8-21(22,18(15)19(16)25)10-11-24(17)13-14-4-3-5-14/h6-7,14,17,25,27H,1-5,8-13H2,(H2,23,26)/t17-,21+,22-/m1/s1 SIJATVAZXUYZQN-VOQZNFBZSA-N 179873 US10231963, Table B.17::US10287250, Compound B.1::US10736890, Compound TABLE B.17::US10752592, Compound TABLE B.1::US11534436, Compound Table B.17::US9133125, Table B, Compound 1::US9656961, Example 00134 Mu-type opioid receptor Homo sapiens 1.40 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179873&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 56847097 313084701 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944059 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1O InChI=1S/C22H30N2O3/c23-20(26)16-7-6-15-12-17-22(27)9-2-1-8-21(22,18(15)19(16)25)10-11-24(17)13-14-4-3-5-14/h6-7,14,17,25,27H,1-5,8-13H2,(H2,23,26)/t17-,21+,22-/m1/s1 SIJATVAZXUYZQN-VOQZNFBZSA-N 179873 US10231963, Table B.17::US10287250, Compound B.1::US10736890, Compound TABLE B.17::US10752592, Compound TABLE B.1::US11534436, Compound Table B.17::US9133125, Table B, Compound 1::US9656961, Example 00134 Mu-type opioid receptor Homo sapiens 4.20 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179873&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 56847097 313084701 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944060 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CC(=C)CC[C@@]34O)c2c1O InChI=1S/C23H30N2O3/c1-14-7-8-23(28)18-11-16-5-6-17(21(24)27)20(26)19(16)22(23,12-14)9-10-25(18)13-15-3-2-4-15/h5-6,15,18,26,28H,1-4,7-13H2,(H2,24,27)/t18-,22-,23-/m1/s1 PXJFQIMTTRRZHS-SXSPYAJSSA-N 179874 US10231963, Table B.18::US10287250, Compound B.3::US10736890, Compound TABLE B.21::US10752592, Compound TABLE B.2::US11534436, Compound Table B.18::US9133125, Table B, Compound 2::US9656961, Example 00135 Mu-type opioid receptor Homo sapiens 0.110 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179874&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582595 313084702 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944061 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CC(=C)CC[C@@]34O)c2c1O InChI=1S/C23H30N2O3/c1-14-7-8-23(28)18-11-16-5-6-17(21(24)27)20(26)19(16)22(23,12-14)9-10-25(18)13-15-3-2-4-15/h5-6,15,18,26,28H,1-4,7-13H2,(H2,24,27)/t18-,22-,23-/m1/s1 PXJFQIMTTRRZHS-SXSPYAJSSA-N 179874 US10231963, Table B.18::US10287250, Compound B.3::US10736890, Compound TABLE B.21::US10752592, Compound TABLE B.2::US11534436, Compound Table B.18::US9133125, Table B, Compound 2::US9656961, Example 00135 Mu-type opioid receptor Homo sapiens 1.10 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179874&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582595 313084702 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944062 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CC(=C)CC[C@@]34O)c2c1O InChI=1S/C23H30N2O3/c1-14-7-8-23(28)18-11-16-5-6-17(21(24)27)20(26)19(16)22(23,12-14)9-10-25(18)13-15-3-2-4-15/h5-6,15,18,26,28H,1-4,7-13H2,(H2,24,27)/t18-,22-,23-/m1/s1 PXJFQIMTTRRZHS-SXSPYAJSSA-N 179874 US10231963, Table B.18::US10287250, Compound B.3::US10736890, Compound TABLE B.21::US10752592, Compound TABLE B.2::US11534436, Compound Table B.18::US9133125, Table B, Compound 2::US9656961, Example 00135 Mu-type opioid receptor Homo sapiens 2.00 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179874&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582595 313084702 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944063 NC(=O)c1ccc2C[C@@H]3[C@@H]4CCC(=C)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C23H30N2O2/c1-14-5-8-18-19-11-16-6-7-17(22(24)27)21(26)20(16)23(18,12-14)9-10-25(19)13-15-3-2-4-15/h6-7,15,18-19,26H,1-5,8-13H2,(H2,24,27)/t18-,19+,23-/m0/s1 QTCGTXSVMPVICZ-YYDVJCTNSA-N 179875 US10231963, Table B.21::US10752592, Compound TABLE B.3::US11534436, Compound Table B.21::US9133125, Table B, Compound 3::US9656961, Example 00138 Mu-type opioid receptor Homo sapiens 0.097 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179875&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582596 313084703 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944064 NC(=O)c1ccc2C[C@@H]3[C@@H]4CCC(=C)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C23H30N2O2/c1-14-5-8-18-19-11-16-6-7-17(22(24)27)21(26)20(16)23(18,12-14)9-10-25(19)13-15-3-2-4-15/h6-7,15,18-19,26H,1-5,8-13H2,(H2,24,27)/t18-,19+,23-/m0/s1 QTCGTXSVMPVICZ-YYDVJCTNSA-N 179875 US10231963, Table B.21::US10752592, Compound TABLE B.3::US11534436, Compound Table B.21::US9133125, Table B, Compound 3::US9656961, Example 00138 Mu-type opioid receptor Homo sapiens 0.530 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179875&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582596 313084703 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944065 NC(=O)c1ccc2C[C@@H]3[C@@H]4CCC(=C)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C23H30N2O2/c1-14-5-8-18-19-11-16-6-7-17(22(24)27)21(26)20(16)23(18,12-14)9-10-25(19)13-15-3-2-4-15/h6-7,15,18-19,26H,1-5,8-13H2,(H2,24,27)/t18-,19+,23-/m0/s1 QTCGTXSVMPVICZ-YYDVJCTNSA-N 179875 US10231963, Table B.21::US10752592, Compound TABLE B.3::US11534436, Compound Table B.21::US9133125, Table B, Compound 3::US9656961, Example 00138 Mu-type opioid receptor Homo sapiens 1.30 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179875&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582596 313084703 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944066 NC(=O)c1ccc2C[C@@H]3[C@@H]4CC[C@H](O)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H30N2O3/c23-21(27)16-6-4-14-10-18-17-7-5-15(25)11-22(17,19(14)20(16)26)8-9-24(18)12-13-2-1-3-13/h4,6,13,15,17-18,25-26H,1-3,5,7-12H2,(H2,23,27)/t15-,17-,18+,22-/m0/s1 BRYWNCYUZQAGMJ-FCQWJQKHSA-N 179876 US10231963, Table B.22::US10287250, Compound B.4::US10736890, Compound TABLE B.22::US10752592, Compound TABLE B.4::US11534436, Compound Table B.22::US9133125, Table B, Compound 4::US9656961, Example 00139 Mu-type opioid receptor Homo sapiens 0.220 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179876&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582746 313084704 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944067 NC(=O)c1ccc2C[C@@H]3[C@@H]4CC[C@H](O)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H30N2O3/c23-21(27)16-6-4-14-10-18-17-7-5-15(25)11-22(17,19(14)20(16)26)8-9-24(18)12-13-2-1-3-13/h4,6,13,15,17-18,25-26H,1-3,5,7-12H2,(H2,23,27)/t15-,17-,18+,22-/m0/s1 BRYWNCYUZQAGMJ-FCQWJQKHSA-N 179876 US10231963, Table B.22::US10287250, Compound B.4::US10736890, Compound TABLE B.22::US10752592, Compound TABLE B.4::US11534436, Compound Table B.22::US9133125, Table B, Compound 4::US9656961, Example 00139 Mu-type opioid receptor Homo sapiens 3.30 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179876&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582746 313084704 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944068 NC(=O)c1ccc2C[C@@H]3[C@@H]4CC[C@H](O)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H30N2O3/c23-21(27)16-6-4-14-10-18-17-7-5-15(25)11-22(17,19(14)20(16)26)8-9-24(18)12-13-2-1-3-13/h4,6,13,15,17-18,25-26H,1-3,5,7-12H2,(H2,23,27)/t15-,17-,18+,22-/m0/s1 BRYWNCYUZQAGMJ-FCQWJQKHSA-N 179876 US10231963, Table B.22::US10287250, Compound B.4::US10736890, Compound TABLE B.22::US10752592, Compound TABLE B.4::US11534436, Compound Table B.22::US9133125, Table B, Compound 4::US9656961, Example 00139 Mu-type opioid receptor Homo sapiens 14.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179876&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582746 313084704 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944069 NC(=O)c1ccc2C[C@@H]3[C@@H]4CCC(=O)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H28N2O3/c23-21(27)16-6-4-14-10-18-17-7-5-15(25)11-22(17,19(14)20(16)26)8-9-24(18)12-13-2-1-3-13/h4,6,13,17-18,26H,1-3,5,7-12H2,(H2,23,27)/t17-,18+,22-/m0/s1 WXCUTWYVZVSZGP-SVMVAKDDSA-N 179877 US10231963, Table B.23::US10736890, Compound TABLE B.23::US10752592, Compound TABLE B.5::US11534436, Compound Table B.23::US9133125, Table B, Compound 5::US9656961, Example 00140 Mu-type opioid receptor Homo sapiens 0.097 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179877&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291189 313084705 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944070 NC(=O)c1ccc2C[C@@H]3[C@@H]4CCC(=O)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H28N2O3/c23-21(27)16-6-4-14-10-18-17-7-5-15(25)11-22(17,19(14)20(16)26)8-9-24(18)12-13-2-1-3-13/h4,6,13,17-18,26H,1-3,5,7-12H2,(H2,23,27)/t17-,18+,22-/m0/s1 WXCUTWYVZVSZGP-SVMVAKDDSA-N 179877 US10231963, Table B.23::US10736890, Compound TABLE B.23::US10752592, Compound TABLE B.5::US11534436, Compound Table B.23::US9133125, Table B, Compound 5::US9656961, Example 00140 Mu-type opioid receptor Homo sapiens 0.390 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179877&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291189 313084705 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944071 NC(=O)c1ccc2C[C@@H]3[C@@H]4CCC(=O)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H28N2O3/c23-21(27)16-6-4-14-10-18-17-7-5-15(25)11-22(17,19(14)20(16)26)8-9-24(18)12-13-2-1-3-13/h4,6,13,17-18,26H,1-3,5,7-12H2,(H2,23,27)/t17-,18+,22-/m0/s1 WXCUTWYVZVSZGP-SVMVAKDDSA-N 179877 US10231963, Table B.23::US10736890, Compound TABLE B.23::US10752592, Compound TABLE B.5::US11534436, Compound Table B.23::US9133125, Table B, Compound 5::US9656961, Example 00140 Mu-type opioid receptor Homo sapiens 1.10 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179877&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291189 313084705 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944072 NC(=O)c1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H30N2O2/c23-21(26)16-8-7-15-12-18-17-6-1-2-9-22(17,19(15)20(16)25)10-11-24(18)13-14-4-3-5-14/h7-8,14,17-18,25H,1-6,9-13H2,(H2,23,26)/t17-,18+,22+/m0/s1 AKNQIOIQJXBDSP-NJNPRVFISA-N 179878 US10231963, Table B.24::US10287250, Compound B.6::US10736890, Compound TABLE B.24::US10752592, Compound TABLE B.6::US11534436, Compound Table B.24::US9133125, Table B, Compound 6::US9656961, Example 00141 Mu-type opioid receptor Homo sapiens 0.120 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179878&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582747 313084706 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944073 NC(=O)c1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H30N2O2/c23-21(26)16-8-7-15-12-18-17-6-1-2-9-22(17,19(15)20(16)25)10-11-24(18)13-14-4-3-5-14/h7-8,14,17-18,25H,1-6,9-13H2,(H2,23,26)/t17-,18+,22+/m0/s1 AKNQIOIQJXBDSP-NJNPRVFISA-N 179878 US10231963, Table B.24::US10287250, Compound B.6::US10736890, Compound TABLE B.24::US10752592, Compound TABLE B.6::US11534436, Compound Table B.24::US9133125, Table B, Compound 6::US9656961, Example 00141 Mu-type opioid receptor Homo sapiens 2.10 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179878&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582747 313084706 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944074 NC(=O)c1ccc2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H30N2O2/c23-21(26)16-8-7-15-12-18-17-6-1-2-9-22(17,19(15)20(16)25)10-11-24(18)13-14-4-3-5-14/h7-8,14,17-18,25H,1-6,9-13H2,(H2,23,26)/t17-,18+,22+/m0/s1 AKNQIOIQJXBDSP-NJNPRVFISA-N 179878 US10231963, Table B.24::US10287250, Compound B.6::US10736890, Compound TABLE B.24::US10752592, Compound TABLE B.6::US11534436, Compound Table B.24::US9133125, Table B, Compound 6::US9656961, Example 00141 Mu-type opioid receptor Homo sapiens 5.00 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179878&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582747 313084706 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944075 NC(=O)c1ccc2C[C@@H]3[C@@H]4CC[C@@H](O)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H30N2O3/c23-21(27)16-6-4-14-10-18-17-7-5-15(25)11-22(17,19(14)20(16)26)8-9-24(18)12-13-2-1-3-13/h4,6,13,15,17-18,25-26H,1-3,5,7-12H2,(H2,23,27)/t15-,17+,18-,22+/m1/s1 BRYWNCYUZQAGMJ-WHEACTPUSA-N 179879 US10231963, Table B.25::US10287250, Compound B.7::US10736890, Compound TABLE B.25::US10752592, Compound TABLE B.7::US11534436, Compound Table B.25::US9133125, Table B, Compound 7::US9656961, Example 00142 Mu-type opioid receptor Homo sapiens 0.130 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179879&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582597 313084707 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944076 NC(=O)c1ccc2C[C@@H]3[C@@H]4CC[C@@H](O)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H30N2O3/c23-21(27)16-6-4-14-10-18-17-7-5-15(25)11-22(17,19(14)20(16)26)8-9-24(18)12-13-2-1-3-13/h4,6,13,15,17-18,25-26H,1-3,5,7-12H2,(H2,23,27)/t15-,17+,18-,22+/m1/s1 BRYWNCYUZQAGMJ-WHEACTPUSA-N 179879 US10231963, Table B.25::US10287250, Compound B.7::US10736890, Compound TABLE B.25::US10752592, Compound TABLE B.7::US11534436, Compound Table B.25::US9133125, Table B, Compound 7::US9656961, Example 00142 Mu-type opioid receptor Homo sapiens 1.50 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179879&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582597 313084707 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944077 NC(=O)c1ccc2C[C@@H]3[C@@H]4CC[C@@H](O)C[C@]4(CCN3CC3CCC3)c2c1O InChI=1S/C22H30N2O3/c23-21(27)16-6-4-14-10-18-17-7-5-15(25)11-22(17,19(14)20(16)26)8-9-24(18)12-13-2-1-3-13/h4,6,13,15,17-18,25-26H,1-3,5,7-12H2,(H2,23,27)/t15-,17+,18-,22+/m1/s1 BRYWNCYUZQAGMJ-WHEACTPUSA-N 179879 US10231963, Table B.25::US10287250, Compound B.7::US10736890, Compound TABLE B.25::US10752592, Compound TABLE B.7::US11534436, Compound Table B.25::US9133125, Table B, Compound 7::US9656961, Example 00142 Mu-type opioid receptor Homo sapiens 3.70 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179879&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582597 313084707 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944078 CC(C)=CCN1CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C22H28N2O4/c1-13(2)6-9-24-10-8-21-12-15(25)5-7-22(21,28)17(24)11-14-3-4-16(20(23)27)19(26)18(14)21/h3-4,6,17,26,28H,5,7-12H2,1-2H3,(H2,23,27)/t17-,21-,22-/m1/s1 APTNTDOSAMTDKL-ZPMCFJSWSA-N 179880 US10231963, Table B.26::US10287250, Compound B.8::US10736890, Compound TABLE B.26::US10752592, Compound TABLE B.8::US11534436, Compound Table B.26::US9133125, Table B, Compound 8::US9656961, Example 00143 Mu-type opioid receptor Homo sapiens 0.560 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179880&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 56847099 313084708 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944079 CC(C)=CCN1CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C22H28N2O4/c1-13(2)6-9-24-10-8-21-12-15(25)5-7-22(21,28)17(24)11-14-3-4-16(20(23)27)19(26)18(14)21/h3-4,6,17,26,28H,5,7-12H2,1-2H3,(H2,23,27)/t17-,21-,22-/m1/s1 APTNTDOSAMTDKL-ZPMCFJSWSA-N 179880 US10231963, Table B.26::US10287250, Compound B.8::US10736890, Compound TABLE B.26::US10752592, Compound TABLE B.8::US11534436, Compound Table B.26::US9133125, Table B, Compound 8::US9656961, Example 00143 Mu-type opioid receptor Homo sapiens 4.20 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179880&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 56847099 313084708 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944080 CC(C)=CCN1CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C22H28N2O4/c1-13(2)6-9-24-10-8-21-12-15(25)5-7-22(21,28)17(24)11-14-3-4-16(20(23)27)19(26)18(14)21/h3-4,6,17,26,28H,5,7-12H2,1-2H3,(H2,23,27)/t17-,21-,22-/m1/s1 APTNTDOSAMTDKL-ZPMCFJSWSA-N 179880 US10231963, Table B.26::US10287250, Compound B.8::US10736890, Compound TABLE B.26::US10752592, Compound TABLE B.8::US11534436, Compound Table B.26::US9133125, Table B, Compound 8::US9656961, Example 00143 Mu-type opioid receptor Homo sapiens 34.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179880&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 56847099 313084708 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944081 CC(C)=CCN1CC[C@]23CC(=C)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C23H30N2O3/c1-14(2)7-10-25-11-9-22-13-15(3)6-8-23(22,28)18(25)12-16-4-5-17(21(24)27)20(26)19(16)22/h4-5,7,18,26,28H,3,6,8-13H2,1-2H3,(H2,24,27)/t18-,22-,23-/m1/s1 NMTVXFMUGDYYGM-SXSPYAJSSA-N 179881 US10231963, Table B.27::US10287250, Compound B.9::US10736890, Compound TABLE B.27::US10752592, Compound TABLE B.9::US11534436, Compound Table B.27::US9133125, Table B, Compound 9::US9656961, Example 00144 Mu-type opioid receptor Homo sapiens 0.500 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179881&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582748 313084709 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944082 CC(C)=CCN1CC[C@]23CC(=C)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C23H30N2O3/c1-14(2)7-10-25-11-9-22-13-15(3)6-8-23(22,28)18(25)12-16-4-5-17(21(24)27)20(26)19(16)22/h4-5,7,18,26,28H,3,6,8-13H2,1-2H3,(H2,24,27)/t18-,22-,23-/m1/s1 NMTVXFMUGDYYGM-SXSPYAJSSA-N 179881 US10231963, Table B.27::US10287250, Compound B.9::US10736890, Compound TABLE B.27::US10752592, Compound TABLE B.9::US11534436, Compound Table B.27::US9133125, Table B, Compound 9::US9656961, Example 00144 Mu-type opioid receptor Homo sapiens 15.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179881&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582748 313084709 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944083 CC(C)=CCN1CC[C@]23CC(=C)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C23H30N2O3/c1-14(2)7-10-25-11-9-22-13-15(3)6-8-23(22,28)18(25)12-16-4-5-17(21(24)27)20(26)19(16)22/h4-5,7,18,26,28H,3,6,8-13H2,1-2H3,(H2,24,27)/t18-,22-,23-/m1/s1 NMTVXFMUGDYYGM-SXSPYAJSSA-N 179881 US10231963, Table B.27::US10287250, Compound B.9::US10736890, Compound TABLE B.27::US10752592, Compound TABLE B.9::US11534436, Compound Table B.27::US9133125, Table B, Compound 9::US9656961, Example 00144 Mu-type opioid receptor Homo sapiens 51.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179881&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582748 313084709 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944084 C[C@H]1[C@H]2Cc3ccc(cc3[C@]1(C)CCN2CC1CCC1)C(N)=O InChI=1S/C20H28N2O/c1-13-18-11-15-6-7-16(19(21)23)10-17(15)20(13,2)8-9-22(18)12-14-4-3-5-14/h6-7,10,13-14,18H,3-5,8-9,11-12H2,1-2H3,(H2,21,23)/t13-,18+,20+/m0/s1 PCGVHHYPMDIXBR-CYFNAFFESA-N 179882 US10287250, Compound B.10::US10752592, Compound TABLE B.10::US9133125, Table B, Compound 10::US9656961, Example 00146 Mu-type opioid receptor Homo sapiens 0.190 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179882&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582904 313084710 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944085 C[C@H]1[C@H]2Cc3ccc(cc3[C@]1(C)CCN2CC1CCC1)C(N)=O InChI=1S/C20H28N2O/c1-13-18-11-15-6-7-16(19(21)23)10-17(15)20(13,2)8-9-22(18)12-14-4-3-5-14/h6-7,10,13-14,18H,3-5,8-9,11-12H2,1-2H3,(H2,21,23)/t13-,18+,20+/m0/s1 PCGVHHYPMDIXBR-CYFNAFFESA-N 179882 US10287250, Compound B.10::US10752592, Compound TABLE B.10::US9133125, Table B, Compound 10::US9656961, Example 00146 Mu-type opioid receptor Homo sapiens 2.30 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179882&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582904 313084710 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944086 C[C@H]1[C@H]2Cc3ccc(cc3[C@]1(C)CCN2CC1CCC1)C(N)=O InChI=1S/C20H28N2O/c1-13-18-11-15-6-7-16(19(21)23)10-17(15)20(13,2)8-9-22(18)12-14-4-3-5-14/h6-7,10,13-14,18H,3-5,8-9,11-12H2,1-2H3,(H2,21,23)/t13-,18+,20+/m0/s1 PCGVHHYPMDIXBR-CYFNAFFESA-N 179882 US10287250, Compound B.10::US10752592, Compound TABLE B.10::US9133125, Table B, Compound 10::US9656961, Example 00146 Mu-type opioid receptor Homo sapiens 14.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179882&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582904 313084710 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944087 C[C@H]1[C@H]2Cc3ccc(cc3[C@]1(C)CCN2CC=C(C)C)C(N)=O InChI=1S/C20H28N2O/c1-13(2)7-9-22-10-8-20(4)14(3)18(22)12-15-5-6-16(19(21)23)11-17(15)20/h5-7,11,14,18H,8-10,12H2,1-4H3,(H2,21,23)/t14-,18+,20+/m0/s1 ASEDTRKYKLTHTA-BOUXLOLZSA-N 50254507 CHEMBL461227::US10287250, Compound B.11::US10752592, Compound TABLE B.11::US9133125, Table B, Compound 11::rel-(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine-8-carboxylic acid amide Mu-type opioid receptor Homo sapiens 2.10 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50254507 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50254507&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44570025 104106712 CHEMBL461227 ZINC40862884 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944088 C[C@H]1[C@H]2Cc3ccc(cc3[C@]1(C)CCN2CC=C(C)C)C(N)=O InChI=1S/C20H28N2O/c1-13(2)7-9-22-10-8-20(4)14(3)18(22)12-15-5-6-16(19(21)23)11-17(15)20/h5-7,11,14,18H,8-10,12H2,1-4H3,(H2,21,23)/t14-,18+,20+/m0/s1 ASEDTRKYKLTHTA-BOUXLOLZSA-N 50254507 CHEMBL461227::US10287250, Compound B.11::US10752592, Compound TABLE B.11::US9133125, Table B, Compound 11::rel-(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine-8-carboxylic acid amide Mu-type opioid receptor Homo sapiens 100.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50254507 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50254507&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44570025 104106712 CHEMBL461227 ZINC40862884 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944089 C[C@H]1[C@H]2Cc3ccc(cc3[C@]1(C)CCN2CC=C(C)C)C(N)=O InChI=1S/C20H28N2O/c1-13(2)7-9-22-10-8-20(4)14(3)18(22)12-15-5-6-16(19(21)23)11-17(15)20/h5-7,11,14,18H,8-10,12H2,1-4H3,(H2,21,23)/t14-,18+,20+/m0/s1 ASEDTRKYKLTHTA-BOUXLOLZSA-N 50254507 CHEMBL461227::US10287250, Compound B.11::US10752592, Compound TABLE B.11::US9133125, Table B, Compound 11::rel-(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine-8-carboxylic acid amide Mu-type opioid receptor Homo sapiens >1300 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50254507 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50254507&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44570025 104106712 CHEMBL461227 ZINC40862884 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944090 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CC(=O)CC[C@@]34O)c2c1O InChI=1S/C22H28N2O4/c23-20(27)16-5-4-14-10-17-22(28)7-6-15(25)11-21(22,18(14)19(16)26)8-9-24(17)12-13-2-1-3-13/h4-5,13,17,26,28H,1-3,6-12H2,(H2,23,27)/t17-,21-,22-/m1/s1 SIIKUSQIIPEOEA-ZPMCFJSWSA-N 50165048 17-cyclobutylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide::CHEMBL370029::US10231963, Table B.16::US10287250, Compound B.12::US10736890, Compound TABLE B.16::US10752592, Compound TABLE B.12::US11534436, Compound Table B.16::US9133125, Table B, Compound 12::US9656961, Example 00133 Mu-type opioid receptor Homo sapiens 0.160 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50165048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50165048&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44401457 104050643 CHEMBL370029 ZINC28523194 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944091 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CC(=O)CC[C@@]34O)c2c1O InChI=1S/C22H28N2O4/c23-20(27)16-5-4-14-10-17-22(28)7-6-15(25)11-21(22,18(14)19(16)26)8-9-24(17)12-13-2-1-3-13/h4-5,13,17,26,28H,1-3,6-12H2,(H2,23,27)/t17-,21-,22-/m1/s1 SIIKUSQIIPEOEA-ZPMCFJSWSA-N 50165048 17-cyclobutylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide::CHEMBL370029::US10231963, Table B.16::US10287250, Compound B.12::US10736890, Compound TABLE B.16::US10752592, Compound TABLE B.12::US11534436, Compound Table B.16::US9133125, Table B, Compound 12::US9656961, Example 00133 Mu-type opioid receptor Homo sapiens 1.000 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50165048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50165048&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44401457 104050643 CHEMBL370029 ZINC28523194 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944092 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CC(=O)CC[C@@]34O)c2c1O InChI=1S/C22H28N2O4/c23-20(27)16-5-4-14-10-17-22(28)7-6-15(25)11-21(22,18(14)19(16)26)8-9-24(17)12-13-2-1-3-13/h4-5,13,17,26,28H,1-3,6-12H2,(H2,23,27)/t17-,21-,22-/m1/s1 SIIKUSQIIPEOEA-ZPMCFJSWSA-N 50165048 17-cyclobutylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide::CHEMBL370029::US10231963, Table B.16::US10287250, Compound B.12::US10736890, Compound TABLE B.16::US10752592, Compound TABLE B.12::US11534436, Compound Table B.16::US9133125, Table B, Compound 12::US9656961, Example 00133 Mu-type opioid receptor Homo sapiens 2.20 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50165048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50165048&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44401457 104050643 CHEMBL370029 ZINC28523194 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944093 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(C[C@@H](O)CC[C@@]34O)c2c1O InChI=1S/C22H30N2O4/c23-20(27)16-5-4-14-10-17-22(28)7-6-15(25)11-21(22,18(14)19(16)26)8-9-24(17)12-13-2-1-3-13/h4-5,13,15,17,25-26,28H,1-3,6-12H2,(H2,23,27)/t15-,17+,21+,22+/m0/s1 NWIALXFYKPFWTR-VYOKXSSZSA-N 50278335 (1R,9R,10S,13S)-17-(cyclobutylmethyl)-3,10,13-trihydroxy-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-triene-4-carboxamide::CHEMBL512150::US10231963, Table B.19::US10287250, Compound B.13::US10736890, Compound TABLE B.19::US10752592, Compound TABLE B.13::US11534436, Compound Table B.19::US9133125, Table B, Compound 13::US9656961, Example 00136 Mu-type opioid receptor Homo sapiens 0.590 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50278335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50278335&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44592053 104120681 CHEMBL512150 ZINC40395789 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944094 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(C[C@@H](O)CC[C@@]34O)c2c1O InChI=1S/C22H30N2O4/c23-20(27)16-5-4-14-10-17-22(28)7-6-15(25)11-21(22,18(14)19(16)26)8-9-24(17)12-13-2-1-3-13/h4-5,13,15,17,25-26,28H,1-3,6-12H2,(H2,23,27)/t15-,17+,21+,22+/m0/s1 NWIALXFYKPFWTR-VYOKXSSZSA-N 50278335 (1R,9R,10S,13S)-17-(cyclobutylmethyl)-3,10,13-trihydroxy-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-triene-4-carboxamide::CHEMBL512150::US10231963, Table B.19::US10287250, Compound B.13::US10736890, Compound TABLE B.19::US10752592, Compound TABLE B.13::US11534436, Compound Table B.19::US9133125, Table B, Compound 13::US9656961, Example 00136 Mu-type opioid receptor Homo sapiens 2.80 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50278335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50278335&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44592053 104120681 CHEMBL512150 ZINC40395789 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944095 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(C[C@@H](O)CC[C@@]34O)c2c1O InChI=1S/C22H30N2O4/c23-20(27)16-5-4-14-10-17-22(28)7-6-15(25)11-21(22,18(14)19(16)26)8-9-24(17)12-13-2-1-3-13/h4-5,13,15,17,25-26,28H,1-3,6-12H2,(H2,23,27)/t15-,17+,21+,22+/m0/s1 NWIALXFYKPFWTR-VYOKXSSZSA-N 50278335 (1R,9R,10S,13S)-17-(cyclobutylmethyl)-3,10,13-trihydroxy-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-triene-4-carboxamide::CHEMBL512150::US10231963, Table B.19::US10287250, Compound B.13::US10736890, Compound TABLE B.19::US10752592, Compound TABLE B.13::US11534436, Compound Table B.19::US9133125, Table B, Compound 13::US9656961, Example 00136 Mu-type opioid receptor Homo sapiens 47.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50278335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50278335&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44592053 104120681 CHEMBL512150 ZINC40395789 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944096 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(C[C@H](O)CC[C@@]34O)c2c1O InChI=1S/C22H30N2O4/c23-20(27)16-5-4-14-10-17-22(28)7-6-15(25)11-21(22,18(14)19(16)26)8-9-24(17)12-13-2-1-3-13/h4-5,13,15,17,25-26,28H,1-3,6-12H2,(H2,23,27)/t15-,17-,21-,22-/m1/s1 NWIALXFYKPFWTR-PVFUSPOPSA-N 50278263 (1R,9R,10S,13R)-17-(cyclobutylmethyl)-3,10,13-trihydroxy-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-triene-4-carboxamide::CHEMBL511645::US10231963, Table B.20::US10287250, Compound B.14::US10736890, Compound TABLE B.20::US10752592, Compound TABLE B.14::US11534436, Compound Table B.20::US9133125, Table B, Compound 14::US9656961, Example 00137 Mu-type opioid receptor Homo sapiens 0.100 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50278263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50278263&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44592015 104120630 CHEMBL511645 ZINC40896777 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944097 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(C[C@H](O)CC[C@@]34O)c2c1O InChI=1S/C22H30N2O4/c23-20(27)16-5-4-14-10-17-22(28)7-6-15(25)11-21(22,18(14)19(16)26)8-9-24(17)12-13-2-1-3-13/h4-5,13,15,17,25-26,28H,1-3,6-12H2,(H2,23,27)/t15-,17-,21-,22-/m1/s1 NWIALXFYKPFWTR-PVFUSPOPSA-N 50278263 (1R,9R,10S,13R)-17-(cyclobutylmethyl)-3,10,13-trihydroxy-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-triene-4-carboxamide::CHEMBL511645::US10231963, Table B.20::US10287250, Compound B.14::US10736890, Compound TABLE B.20::US10752592, Compound TABLE B.14::US11534436, Compound Table B.20::US9133125, Table B, Compound 14::US9656961, Example 00137 Mu-type opioid receptor Homo sapiens 0.980 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50278263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50278263&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44592015 104120630 CHEMBL511645 ZINC40896777 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944098 NC(=O)c1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(C[C@H](O)CC[C@@]34O)c2c1O InChI=1S/C22H30N2O4/c23-20(27)16-5-4-14-10-17-22(28)7-6-15(25)11-21(22,18(14)19(16)26)8-9-24(17)12-13-2-1-3-13/h4-5,13,15,17,25-26,28H,1-3,6-12H2,(H2,23,27)/t15-,17-,21-,22-/m1/s1 NWIALXFYKPFWTR-PVFUSPOPSA-N 50278263 (1R,9R,10S,13R)-17-(cyclobutylmethyl)-3,10,13-trihydroxy-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-triene-4-carboxamide::CHEMBL511645::US10231963, Table B.20::US10287250, Compound B.14::US10736890, Compound TABLE B.20::US10752592, Compound TABLE B.14::US11534436, Compound Table B.20::US9133125, Table B, Compound 14::US9656961, Example 00137 Mu-type opioid receptor Homo sapiens 3.80 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50278263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50278263&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 44592015 104120630 CHEMBL511645 ZINC40896777 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944099 C[C@H](C1CC1)N1CC[C@@]2(C)C(C)[C@H]1Cc1ccc(O)cc21 InChI=1S/C19H27NO/c1-12-18-10-15-6-7-16(21)11-17(15)19(12,3)8-9-20(18)13(2)14-4-5-14/h6-7,11-14,18,21H,4-5,8-10H2,1-3H3/t12?,13-,18-,19+/m1/s1 USUBALPLEUZHID-ZCUCUALCSA-N 179883 US10287250, Example 00074::US10752592, Compound TABLE C.-13::US9133125, Table C, Compound 1::US9656961, Example 00145 Mu-type opioid receptor Homo sapiens 0.100 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179883&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862192 313084711 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944100 C[C@H](C1CC1)N1CC[C@@]2(C)C(C)[C@H]1Cc1ccc(O)cc21 InChI=1S/C19H27NO/c1-12-18-10-15-6-7-16(21)11-17(15)19(12,3)8-9-20(18)13(2)14-4-5-14/h6-7,11-14,18,21H,4-5,8-10H2,1-3H3/t12?,13-,18-,19+/m1/s1 USUBALPLEUZHID-ZCUCUALCSA-N 179883 US10287250, Example 00074::US10752592, Compound TABLE C.-13::US9133125, Table C, Compound 1::US9656961, Example 00145 Mu-type opioid receptor Homo sapiens 3.50 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179883&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862192 313084711 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944101 C[C@H](C1CC1)N1CC[C@@]2(C)C(C)[C@H]1Cc1ccc(O)cc21 InChI=1S/C19H27NO/c1-12-18-10-15-6-7-16(21)11-17(15)19(12,3)8-9-20(18)13(2)14-4-5-14/h6-7,11-14,18,21H,4-5,8-10H2,1-3H3/t12?,13-,18-,19+/m1/s1 USUBALPLEUZHID-ZCUCUALCSA-N 179883 US10287250, Example 00074::US10752592, Compound TABLE C.-13::US9133125, Table C, Compound 1::US9656961, Example 00145 Mu-type opioid receptor Homo sapiens 3.30 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179883&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862192 313084711 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944102 C[C@@H](C1CC1)N1CC[C@@]2(C)C(C)[C@H]1Cc1ccc(O)cc21 InChI=1S/C19H27NO/c1-12-18-10-15-6-7-16(21)11-17(15)19(12,3)8-9-20(18)13(2)14-4-5-14/h6-7,11-14,18,21H,4-5,8-10H2,1-3H3/t12?,13-,18+,19-/m0/s1 USUBALPLEUZHID-VCCUOBBTSA-N 179884 US10287250, Compound C.2::US10752592, Compound TABLE C.-12::US9133125, Table C, Compound 2::US9656961, Example 00147 Mu-type opioid receptor Homo sapiens 22.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179884&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862193 313084712 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944103 C[C@@H](C1CC1)N1CC[C@@]2(C)C(C)[C@H]1Cc1ccc(O)cc21 InChI=1S/C19H27NO/c1-12-18-10-15-6-7-16(21)11-17(15)19(12,3)8-9-20(18)13(2)14-4-5-14/h6-7,11-14,18,21H,4-5,8-10H2,1-3H3/t12?,13-,18+,19-/m0/s1 USUBALPLEUZHID-VCCUOBBTSA-N 179884 US10287250, Compound C.2::US10752592, Compound TABLE C.-12::US9133125, Table C, Compound 2::US9656961, Example 00147 Mu-type opioid receptor Homo sapiens 60.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179884&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862193 313084712 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944104 C[C@@H](C1CC1)N1CC[C@@]2(C)C(C)[C@H]1Cc1ccc(O)cc21 InChI=1S/C19H27NO/c1-12-18-10-15-6-7-16(21)11-17(15)19(12,3)8-9-20(18)13(2)14-4-5-14/h6-7,11-14,18,21H,4-5,8-10H2,1-3H3/t12?,13-,18+,19-/m0/s1 USUBALPLEUZHID-VCCUOBBTSA-N 179884 US10287250, Compound C.2::US10752592, Compound TABLE C.-12::US9133125, Table C, Compound 2::US9656961, Example 00147 Mu-type opioid receptor Homo sapiens 950 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179884&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862193 313084712 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944105 CC1C2Cc3ccc(O)cc3[C@]1(C)CCN2CC1(C)CC1 InChI=1S/C19H27NO/c1-13-17-10-14-4-5-15(21)11-16(14)19(13,3)8-9-20(17)12-18(2)6-7-18/h4-5,11,13,17,21H,6-10,12H2,1-3H3/t13?,17?,19-/m1/s1 CHPZBNWSVQPLCP-GFEPPQMASA-N 179885 US10287250, Compound C.3::US10752592, Compound TABLE C.-11::US9133125, Table C, Compound 3::US9656961, Example 00149 Mu-type opioid receptor Homo sapiens 0.820 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179885&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862196 313084713 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944106 CC1C2Cc3ccc(O)cc3[C@]1(C)CCN2CC1(C)CC1 InChI=1S/C19H27NO/c1-13-17-10-14-4-5-15(21)11-16(14)19(13,3)8-9-20(17)12-18(2)6-7-18/h4-5,11,13,17,21H,6-10,12H2,1-3H3/t13?,17?,19-/m1/s1 CHPZBNWSVQPLCP-GFEPPQMASA-N 179885 US10287250, Compound C.3::US10752592, Compound TABLE C.-11::US9133125, Table C, Compound 3::US9656961, Example 00149 Mu-type opioid receptor Homo sapiens 13.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179885&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862196 313084713 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944107 CC1C2Cc3ccc(O)cc3[C@]1(C)CCN2CC1(C)CC1 InChI=1S/C19H27NO/c1-13-17-10-14-4-5-15(21)11-16(14)19(13,3)8-9-20(17)12-18(2)6-7-18/h4-5,11,13,17,21H,6-10,12H2,1-3H3/t13?,17?,19-/m1/s1 CHPZBNWSVQPLCP-GFEPPQMASA-N 179885 US10287250, Compound C.3::US10752592, Compound TABLE C.-11::US9133125, Table C, Compound 3::US9656961, Example 00149 Mu-type opioid receptor Homo sapiens 85.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179885&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862196 313084713 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944108 CC1C2Cc3ccc(O)cc3[C@]1(C)CCN2CC(C)(C)O InChI=1S/C18H27NO2/c1-12-16-9-13-5-6-14(20)10-15(13)18(12,4)7-8-19(16)11-17(2,3)21/h5-6,10,12,16,20-21H,7-9,11H2,1-4H3/t12?,16?,18-/m1/s1 BYGCDFRQFJKYAY-WBAAUIMVSA-N 179886 US10287250, Compound C.4::US10752592, Compound TABLE C.-10::US9133125, Table C, Compound 4::US9656961, Example 00150 Mu-type opioid receptor Homo sapiens 4.60 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179886&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862194 313084714 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944109 CC1C2Cc3ccc(O)cc3[C@]1(C)CCN2CC(C)(C)O InChI=1S/C18H27NO2/c1-12-16-9-13-5-6-14(20)10-15(13)18(12,4)7-8-19(16)11-17(2,3)21/h5-6,10,12,16,20-21H,7-9,11H2,1-4H3/t12?,16?,18-/m1/s1 BYGCDFRQFJKYAY-WBAAUIMVSA-N 179886 US10287250, Compound C.4::US10752592, Compound TABLE C.-10::US9133125, Table C, Compound 4::US9656961, Example 00150 Mu-type opioid receptor Homo sapiens 84.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179886&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862194 313084714 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944110 CC1C2Cc3ccc(O)cc3[C@]1(C)CCN2CC(C)(C)O InChI=1S/C18H27NO2/c1-12-16-9-13-5-6-14(20)10-15(13)18(12,4)7-8-19(16)11-17(2,3)21/h5-6,10,12,16,20-21H,7-9,11H2,1-4H3/t12?,16?,18-/m1/s1 BYGCDFRQFJKYAY-WBAAUIMVSA-N 179886 US10287250, Compound C.4::US10752592, Compound TABLE C.-10::US9133125, Table C, Compound 4::US9656961, Example 00150 Mu-type opioid receptor Homo sapiens 210 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179886&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862194 313084714 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944111 COCCN1CC[C@]2(C)[C@@H](C)[C@H]1Cc1ccc(O)cc21 InChI=1S/C17H25NO2/c1-12-16-10-13-4-5-14(19)11-15(13)17(12,2)6-7-18(16)8-9-20-3/h4-5,11-12,16,19H,6-10H2,1-3H3/t12-,16+,17+/m0/s1 DZDGGJQZRLCVQI-JCURWCKSSA-N 179887 US10287250, Compound C.5::US10752592, Compound TABLE C.-9::US9133125, Table C, Compound 5::US9656961, Example 00152 Mu-type opioid receptor Homo sapiens 0.110 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179887&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582305 313084715 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944112 COCCN1CC[C@]2(C)[C@@H](C)[C@H]1Cc1ccc(O)cc21 InChI=1S/C17H25NO2/c1-12-16-10-13-4-5-14(19)11-15(13)17(12,2)6-7-18(16)8-9-20-3/h4-5,11-12,16,19H,6-10H2,1-3H3/t12-,16+,17+/m0/s1 DZDGGJQZRLCVQI-JCURWCKSSA-N 179887 US10287250, Compound C.5::US10752592, Compound TABLE C.-9::US9133125, Table C, Compound 5::US9656961, Example 00152 Mu-type opioid receptor Homo sapiens 4.80 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179887&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582305 313084715 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944113 COCCN1CC[C@]2(C)[C@@H](C)[C@H]1Cc1ccc(O)cc21 InChI=1S/C17H25NO2/c1-12-16-10-13-4-5-14(19)11-15(13)17(12,2)6-7-18(16)8-9-20-3/h4-5,11-12,16,19H,6-10H2,1-3H3/t12-,16+,17+/m0/s1 DZDGGJQZRLCVQI-JCURWCKSSA-N 179887 US10287250, Compound C.5::US10752592, Compound TABLE C.-9::US9133125, Table C, Compound 5::US9656961, Example 00152 Mu-type opioid receptor Homo sapiens 26.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179887&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582305 313084715 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944114 CC1C2Cc3ccc(cc3[C@]1(C)CCN2CC1(C)CC1)C(N)=O InChI=1S/C20H28N2O/c1-13-17-11-14-4-5-15(18(21)23)10-16(14)20(13,3)8-9-22(17)12-19(2)6-7-19/h4-5,10,13,17H,6-9,11-12H2,1-3H3,(H2,21,23)/t13?,17?,20-/m1/s1 JSRNTMOLJYTAIF-RJGDCVCESA-N 179896 US10287250, Compound C.14::US10752592, Compound TABLE C.0::US9133125, Table C, Compound 14::US9656961, Example 00164 Mu-type opioid receptor Homo sapiens 1.20 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179896&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862198 313084723 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944115 CC1C2Cc3ccc(cc3[C@]1(C)CCN2CC1(C)CC1)C(N)=O InChI=1S/C20H28N2O/c1-13-17-11-14-4-5-15(18(21)23)10-16(14)20(13,3)8-9-22(17)12-19(2)6-7-19/h4-5,10,13,17H,6-9,11-12H2,1-3H3,(H2,21,23)/t13?,17?,20-/m1/s1 JSRNTMOLJYTAIF-RJGDCVCESA-N 179896 US10287250, Compound C.14::US10752592, Compound TABLE C.0::US9133125, Table C, Compound 14::US9656961, Example 00164 Mu-type opioid receptor Homo sapiens 44.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179896&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862198 313084723 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944116 C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2CC1CC1)C(=O)NCCc1ccc(cc1)-c1ccc(O)nc1 InChI=1S/C32H37N3O2/c1-21-29-18-25-9-10-26(17-28(25)32(21,2)14-16-35(29)20-23-3-4-23)31(37)33-15-13-22-5-7-24(8-6-22)27-11-12-30(36)34-19-27/h5-12,17,19,21,23,29H,3-4,13-16,18,20H2,1-2H3,(H,33,37)(H,34,36)/t21-,29+,32-/m0/s1 MJARPNLDLZUFSF-NCPGCRMVSA-N 179889 US10752592, Compound TABLE C.-7::US9133125, Table C, Compound 7 Mu-type opioid receptor Homo sapiens 0.680 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179889&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862197 313084717 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944117 C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2CC1CC1)C(=O)NCCc1ccc(cc1)-c1ccc(O)nc1 InChI=1S/C32H37N3O2/c1-21-29-18-25-9-10-26(17-28(25)32(21,2)14-16-35(29)20-23-3-4-23)31(37)33-15-13-22-5-7-24(8-6-22)27-11-12-30(36)34-19-27/h5-12,17,19,21,23,29H,3-4,13-16,18,20H2,1-2H3,(H,33,37)(H,34,36)/t21-,29+,32-/m0/s1 MJARPNLDLZUFSF-NCPGCRMVSA-N 179889 US10752592, Compound TABLE C.-7::US9133125, Table C, Compound 7 Mu-type opioid receptor Homo sapiens 22.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179889&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862197 313084717 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944118 C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2CC1CC1)C(=O)NCCc1ccc(cc1)-c1ccc(O)nc1 InChI=1S/C32H37N3O2/c1-21-29-18-25-9-10-26(17-28(25)32(21,2)14-16-35(29)20-23-3-4-23)31(37)33-15-13-22-5-7-24(8-6-22)27-11-12-30(36)34-19-27/h5-12,17,19,21,23,29H,3-4,13-16,18,20H2,1-2H3,(H,33,37)(H,34,36)/t21-,29+,32-/m0/s1 MJARPNLDLZUFSF-NCPGCRMVSA-N 179889 US10752592, Compound TABLE C.-7::US9133125, Table C, Compound 7 Mu-type opioid receptor Homo sapiens 47.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179889&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862197 313084717 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944119 C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2CC1CC1)C(=O)NCCc1ccc(cc1)-c1cn[nH]c1 179890 US10752592, Compound TABLE C.-6::US9133125, Table C, Compound 8 Mu-type opioid receptor Homo sapiens 0.270 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179890&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862195 313084718 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944120 C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2CC1CC1)C(=O)NCCc1ccc(cc1)-c1cn[nH]c1 179890 US10752592, Compound TABLE C.-6::US9133125, Table C, Compound 8 Mu-type opioid receptor Homo sapiens 5.20 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179890&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862195 313084718 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944121 C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2CC1CC1)C(=O)NCCc1ccc(cc1)-c1cn[nH]c1 179890 US10752592, Compound TABLE C.-6::US9133125, Table C, Compound 8 Mu-type opioid receptor Homo sapiens 18.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179890&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862195 313084718 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944122 Oc1c(ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC(=O)CC[C@@]34O)c12)C(=O)NCCc1ccc(cc1)-c1cccnc1 InChI=1S/C34H37N3O4/c38-27-11-13-34(41)29-18-25-9-10-28(31(39)30(25)33(34,19-27)14-17-37(29)21-23-3-4-23)32(40)36-16-12-22-5-7-24(8-6-22)26-2-1-15-35-20-26/h1-2,5-10,15,20,23,29,39,41H,3-4,11-14,16-19,21H2,(H,36,40)/t29-,33-,34-/m1/s1 LDQZCGLBZJGWLP-QVLFBZODSA-N 179891 US10287250, Compound C.9::US10752592, Compound TABLE C.-5::US9133125, Table C, Compound 9::US9656961, Example 00159 Mu-type opioid receptor Homo sapiens 0.370 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179891&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862199 313084719 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944123 Oc1c(ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC(=O)CC[C@@]34O)c12)C(=O)NCCc1ccc(cc1)-c1cccnc1 InChI=1S/C34H37N3O4/c38-27-11-13-34(41)29-18-25-9-10-28(31(39)30(25)33(34,19-27)14-17-37(29)21-23-3-4-23)32(40)36-16-12-22-5-7-24(8-6-22)26-2-1-15-35-20-26/h1-2,5-10,15,20,23,29,39,41H,3-4,11-14,16-19,21H2,(H,36,40)/t29-,33-,34-/m1/s1 LDQZCGLBZJGWLP-QVLFBZODSA-N 179891 US10287250, Compound C.9::US10752592, Compound TABLE C.-5::US9133125, Table C, Compound 9::US9656961, Example 00159 Mu-type opioid receptor Homo sapiens 2.90 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179891&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862199 313084719 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944124 Oc1c(ccc2C[C@H]3N(CC4CC4)CC[C@@]4(CC(=O)CC[C@@]34O)c12)C(=O)NCCc1ccc(cc1)-c1cccnc1 InChI=1S/C34H37N3O4/c38-27-11-13-34(41)29-18-25-9-10-28(31(39)30(25)33(34,19-27)14-17-37(29)21-23-3-4-23)32(40)36-16-12-22-5-7-24(8-6-22)26-2-1-15-35-20-26/h1-2,5-10,15,20,23,29,39,41H,3-4,11-14,16-19,21H2,(H,36,40)/t29-,33-,34-/m1/s1 LDQZCGLBZJGWLP-QVLFBZODSA-N 179891 US10287250, Compound C.9::US10752592, Compound TABLE C.-5::US9133125, Table C, Compound 9::US9656961, Example 00159 Mu-type opioid receptor Homo sapiens 1.50 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179891&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862199 313084719 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944125 C[C@@]12CCCCC[C@@H](Cc3ccc(cc13)C(N)=O)[C@@H]2N InChI=1S/C17H24N2O/c1-17-8-4-2-3-5-12(15(17)18)9-11-6-7-13(16(19)20)10-14(11)17/h6-7,10,12,15H,2-5,8-9,18H2,1H3,(H2,19,20)/t12-,15-,17+/m0/s1 RCBJWIIGHMFUGM-YLQAJVPDSA-N 179892 US10287250, Compound C.11::US10752592, Compound TABLE C.-3::US9133125, Table C, Compound 10::US9133125, Table C, Compound 11::US9656961, Example 00161 Mu-type opioid receptor Homo sapiens 2.30 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179892&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862200 313084720 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944126 C[C@@]12CCCCC[C@@H](Cc3ccc(cc13)C(N)=O)[C@@H]2N InChI=1S/C17H24N2O/c1-17-8-4-2-3-5-12(15(17)18)9-11-6-7-13(16(19)20)10-14(11)17/h6-7,10,12,15H,2-5,8-9,18H2,1H3,(H2,19,20)/t12-,15-,17+/m0/s1 RCBJWIIGHMFUGM-YLQAJVPDSA-N 179892 US10287250, Compound C.11::US10752592, Compound TABLE C.-3::US9133125, Table C, Compound 10::US9133125, Table C, Compound 11::US9656961, Example 00161 Mu-type opioid receptor Homo sapiens 62.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179892&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862200 313084720 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944127 C[C@@]12CCCCC[C@@H](Cc3ccc(cc13)C(N)=O)[C@@H]2N InChI=1S/C17H24N2O/c1-17-8-4-2-3-5-12(15(17)18)9-11-6-7-13(16(19)20)10-14(11)17/h6-7,10,12,15H,2-5,8-9,18H2,1H3,(H2,19,20)/t12-,15-,17+/m0/s1 RCBJWIIGHMFUGM-YLQAJVPDSA-N 179892 US10287250, Compound C.11::US10752592, Compound TABLE C.-3::US9133125, Table C, Compound 10::US9133125, Table C, Compound 11::US9656961, Example 00161 Mu-type opioid receptor Homo sapiens 170 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179892&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862200 313084720 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944128 C[C@@]12CCCCC[C@@H](Cc3ccc(cc13)C(N)=O)[C@@H]2N InChI=1S/C17H24N2O/c1-17-8-4-2-3-5-12(15(17)18)9-11-6-7-13(16(19)20)10-14(11)17/h6-7,10,12,15H,2-5,8-9,18H2,1H3,(H2,19,20)/t12-,15-,17+/m0/s1 RCBJWIIGHMFUGM-YLQAJVPDSA-N 179892 US10287250, Compound C.11::US10752592, Compound TABLE C.-3::US9133125, Table C, Compound 10::US9133125, Table C, Compound 11::US9656961, Example 00161 Mu-type opioid receptor Homo sapiens 3.00 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179892&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862200 313084720 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944129 C[C@@]12CCCCC[C@@H](Cc3ccc(cc13)C(N)=O)[C@@H]2N InChI=1S/C17H24N2O/c1-17-8-4-2-3-5-12(15(17)18)9-11-6-7-13(16(19)20)10-14(11)17/h6-7,10,12,15H,2-5,8-9,18H2,1H3,(H2,19,20)/t12-,15-,17+/m0/s1 RCBJWIIGHMFUGM-YLQAJVPDSA-N 179892 US10287250, Compound C.11::US10752592, Compound TABLE C.-3::US9133125, Table C, Compound 10::US9133125, Table C, Compound 11::US9656961, Example 00161 Mu-type opioid receptor Homo sapiens 41.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179892&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862200 313084720 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944130 C[C@@]12CCCCC[C@@H](Cc3ccc(cc13)C(N)=O)[C@@H]2N InChI=1S/C17H24N2O/c1-17-8-4-2-3-5-12(15(17)18)9-11-6-7-13(16(19)20)10-14(11)17/h6-7,10,12,15H,2-5,8-9,18H2,1H3,(H2,19,20)/t12-,15-,17+/m0/s1 RCBJWIIGHMFUGM-YLQAJVPDSA-N 179892 US10287250, Compound C.11::US10752592, Compound TABLE C.-3::US9133125, Table C, Compound 10::US9133125, Table C, Compound 11::US9656961, Example 00161 Mu-type opioid receptor Homo sapiens 170 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179892&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862200 313084720 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944131 CN1CCC23[C@H](CCC[C@H]2C1)Oc1c3cccc1C(N)=O InChI=1S/C17H22N2O2/c1-19-9-8-17-11(10-19)4-2-7-14(17)21-15-12(16(18)20)5-3-6-13(15)17/h3,5-6,11,14H,2,4,7-10H2,1H3,(H2,18,20)/t11-,14-,17?/m0/s1 SZOGKPIPCIDKSZ-UKOIWPHMSA-N 457933 US10752592, Compound TABLE C.-2 Mu-type opioid receptor Homo sapiens 23.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457933&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117943728 441289210 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944132 CN1CCC23[C@H](CCC[C@H]2C1)Oc1c3cccc1C(N)=O InChI=1S/C17H22N2O2/c1-19-9-8-17-11(10-19)4-2-7-14(17)21-15-12(16(18)20)5-3-6-13(15)17/h3,5-6,11,14H,2,4,7-10H2,1H3,(H2,18,20)/t11-,14-,17?/m0/s1 SZOGKPIPCIDKSZ-UKOIWPHMSA-N 457933 US10752592, Compound TABLE C.-2 Mu-type opioid receptor Homo sapiens 190 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457933&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117943728 441289210 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944133 CN1CCC23[C@H](CCC[C@H]2C1)Oc1c3cccc1C(N)=O InChI=1S/C17H22N2O2/c1-19-9-8-17-11(10-19)4-2-7-14(17)21-15-12(16(18)20)5-3-6-13(15)17/h3,5-6,11,14H,2,4,7-10H2,1H3,(H2,18,20)/t11-,14-,17?/m0/s1 SZOGKPIPCIDKSZ-UKOIWPHMSA-N 457933 US10752592, Compound TABLE C.-2 Mu-type opioid receptor Homo sapiens >3000 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=457933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=457933&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117943728 441289210 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944134 CCCCCCN1CCC(CC1)(C(=O)N(C)CC)c1cccc(O)c1 InChI=1S/C21H34N2O2/c1-4-6-7-8-14-23-15-12-21(13-16-23,20(25)22(3)5-2)18-10-9-11-19(24)17-18/h9-11,17,24H,4-8,12-16H2,1-3H3 AOOXYUOJIHILLE-UHFFFAOYSA-N 179895 US10287250, Compound C.13::US10752592, Compound TABLE C.-1::US9133125, Table C, Compound 13::US9656961, Example 00163 Mu-type opioid receptor Homo sapiens 4.40 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179895&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86580957 313084722 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944135 CCCCCCN1CCC(CC1)(C(=O)N(C)CC)c1cccc(O)c1 InChI=1S/C21H34N2O2/c1-4-6-7-8-14-23-15-12-21(13-16-23,20(25)22(3)5-2)18-10-9-11-19(24)17-18/h9-11,17,24H,4-8,12-16H2,1-3H3 AOOXYUOJIHILLE-UHFFFAOYSA-N 179895 US10287250, Compound C.13::US10752592, Compound TABLE C.-1::US9133125, Table C, Compound 13::US9656961, Example 00163 Mu-type opioid receptor Homo sapiens 20.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179895&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86580957 313084722 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944136 CCCCCCN1CCC(CC1)(C(=O)N(C)CC)c1cccc(O)c1 InChI=1S/C21H34N2O2/c1-4-6-7-8-14-23-15-12-21(13-16-23,20(25)22(3)5-2)18-10-9-11-19(24)17-18/h9-11,17,24H,4-8,12-16H2,1-3H3 AOOXYUOJIHILLE-UHFFFAOYSA-N 179895 US10287250, Compound C.13::US10752592, Compound TABLE C.-1::US9133125, Table C, Compound 13::US9656961, Example 00163 Mu-type opioid receptor Homo sapiens 340 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179895&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86580957 313084722 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944137 CC1C2Cc3ccc(cc3[C@]1(C)CCN2CC1(C)CC1)C(N)=O InChI=1S/C20H28N2O/c1-13-17-11-14-4-5-15(18(21)23)10-16(14)20(13,3)8-9-22(17)12-19(2)6-7-19/h4-5,10,13,17H,6-9,11-12H2,1-3H3,(H2,21,23)/t13?,17?,20-/m1/s1 JSRNTMOLJYTAIF-RJGDCVCESA-N 179896 US10287250, Compound C.14::US10752592, Compound TABLE C.0::US9133125, Table C, Compound 14::US9656961, Example 00164 Mu-type opioid receptor Homo sapiens 1.20 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179896&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862198 313084723 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944138 CC1C2Cc3ccc(cc3[C@]1(C)CCN2CC1(C)CC1)C(N)=O InChI=1S/C20H28N2O/c1-13-17-11-14-4-5-15(18(21)23)10-16(14)20(13,3)8-9-22(17)12-19(2)6-7-19/h4-5,10,13,17H,6-9,11-12H2,1-3H3,(H2,21,23)/t13?,17?,20-/m1/s1 JSRNTMOLJYTAIF-RJGDCVCESA-N 179896 US10287250, Compound C.14::US10752592, Compound TABLE C.0::US9133125, Table C, Compound 14::US9656961, Example 00164 Mu-type opioid receptor Homo sapiens 44.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179896&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862198 313084723 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944139 C[C@H](C1CC1)N1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(cc31)C(N)=O InChI=1S/C22H30N2O/c1-14(15-5-6-15)24-11-10-22-9-3-2-4-18(22)20(24)13-16-7-8-17(21(23)25)12-19(16)22/h7-8,12,14-15,18,20H,2-6,9-11,13H2,1H3,(H2,23,25)/t14-,18+,20-,22-/m1/s1 WKSWYCJGHDWJFK-PDPGBCDDSA-N 179897 US10287250, Compound 1::US10736890, Compound TABLE C.1::US10752592, Compound TABLE D.1::US11534436, Compound Table C.1::US9133125, Table D, Compound 1::US9656961, Example 00165 Mu-type opioid receptor Homo sapiens 0.083 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179897&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291190 313084724 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944140 C[C@H](C1CC1)N1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(cc31)C(N)=O InChI=1S/C22H30N2O/c1-14(15-5-6-15)24-11-10-22-9-3-2-4-18(22)20(24)13-16-7-8-17(21(23)25)12-19(16)22/h7-8,12,14-15,18,20H,2-6,9-11,13H2,1H3,(H2,23,25)/t14-,18+,20-,22-/m1/s1 WKSWYCJGHDWJFK-PDPGBCDDSA-N 179897 US10287250, Compound 1::US10736890, Compound TABLE C.1::US10752592, Compound TABLE D.1::US11534436, Compound Table C.1::US9133125, Table D, Compound 1::US9656961, Example 00165 Mu-type opioid receptor Homo sapiens 1.30 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179897&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291190 313084724 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944141 C[C@H](C1CC1)N1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(cc31)C(N)=O InChI=1S/C22H30N2O/c1-14(15-5-6-15)24-11-10-22-9-3-2-4-18(22)20(24)13-16-7-8-17(21(23)25)12-19(16)22/h7-8,12,14-15,18,20H,2-6,9-11,13H2,1H3,(H2,23,25)/t14-,18+,20-,22-/m1/s1 WKSWYCJGHDWJFK-PDPGBCDDSA-N 179897 US10287250, Compound 1::US10736890, Compound TABLE C.1::US10752592, Compound TABLE D.1::US11534436, Compound Table C.1::US9133125, Table D, Compound 1::US9656961, Example 00165 Mu-type opioid receptor Homo sapiens 1.70 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179897&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291190 313084724 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944142 C[C@@H](C1CC1)N1CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C22H28N2O4/c1-12(13-2-3-13)24-9-8-21-11-15(25)6-7-22(21,28)17(24)10-14-4-5-16(20(23)27)19(26)18(14)21/h4-5,12-13,17,26,28H,2-3,6-11H2,1H3,(H2,23,27)/t12-,17+,21+,22+/m0/s1 PEWWIMGLMQXNCF-ZFSUOAISSA-N 179898 US10231963, Table C.2::US10287250, Compound 2::US10736890, Compound TABLE C.2::US10752592, Compound TABLE D.2::US11534436, Compound Table C.2::US9133125, Table D, Compound 2::US9656961, Example 00166 Mu-type opioid receptor Homo sapiens 0.140 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179898&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291191 313084725 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944143 C[C@@H](C1CC1)N1CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C22H28N2O4/c1-12(13-2-3-13)24-9-8-21-11-15(25)6-7-22(21,28)17(24)10-14-4-5-16(20(23)27)19(26)18(14)21/h4-5,12-13,17,26,28H,2-3,6-11H2,1H3,(H2,23,27)/t12-,17+,21+,22+/m0/s1 PEWWIMGLMQXNCF-ZFSUOAISSA-N 179898 US10231963, Table C.2::US10287250, Compound 2::US10736890, Compound TABLE C.2::US10752592, Compound TABLE D.2::US11534436, Compound Table C.2::US9133125, Table D, Compound 2::US9656961, Example 00166 Mu-type opioid receptor Homo sapiens 0.650 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179898&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291191 313084725 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944144 C[C@H](C1CC1)N1CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C22H28N2O4/c1-12(13-2-3-13)24-9-8-21-11-15(25)6-7-22(21,28)17(24)10-14-4-5-16(20(23)27)19(26)18(14)21/h4-5,12-13,17,26,28H,2-3,6-11H2,1H3,(H2,23,27)/t12-,17-,21-,22-/m1/s1 PEWWIMGLMQXNCF-OHFGDUEGSA-N 179899 US10231963, Table C.3::US10287250, Compound 3::US10736890, Compound TABLE C.3::US10752592, Compound TABLE D.3::US11534436, Compound Table C.3::US9133125, Table D, Compound 3::US9656961, Example 00167 Mu-type opioid receptor Homo sapiens 5.80 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179899&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291192 313084726 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944145 C[C@H](C1CC1)N1CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C22H28N2O4/c1-12(13-2-3-13)24-9-8-21-11-15(25)6-7-22(21,28)17(24)10-14-4-5-16(20(23)27)19(26)18(14)21/h4-5,12-13,17,26,28H,2-3,6-11H2,1H3,(H2,23,27)/t12-,17-,21-,22-/m1/s1 PEWWIMGLMQXNCF-OHFGDUEGSA-N 179899 US10231963, Table C.3::US10287250, Compound 3::US10736890, Compound TABLE C.3::US10752592, Compound TABLE D.3::US11534436, Compound Table C.3::US9133125, Table D, Compound 3::US9656961, Example 00167 Mu-type opioid receptor Homo sapiens 43.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179899&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291192 313084726 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944146 C[C@H](C1CCC1)N1CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C23H30N2O4/c1-13(14-3-2-4-14)25-10-9-22-12-16(26)7-8-23(22,29)18(25)11-15-5-6-17(21(24)28)20(27)19(15)22/h5-6,13-14,18,27,29H,2-4,7-12H2,1H3,(H2,24,28)/t13-,18-,22-,23-/m1/s1 JWIGXHPEGWQVAB-HUDPDHSWSA-N 179900 US10231963, Table C.4::US10287250, Compound 4::US10736890, Compound TABLE C.4::US10752592, Compound TABLE D.4::US11534436, Compound Table C.4::US9133125, Table D, Compound 4::US9656961, Example 00168 Mu-type opioid receptor Homo sapiens 1.20 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179900&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291193 313084727 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944147 C[C@H](C1CCC1)N1CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c31 InChI=1S/C23H30N2O4/c1-13(14-3-2-4-14)25-10-9-22-12-16(26)7-8-23(22,29)18(25)11-15-5-6-17(21(24)28)20(27)19(15)22/h5-6,13-14,18,27,29H,2-4,7-12H2,1H3,(H2,24,28)/t13-,18-,22-,23-/m1/s1 JWIGXHPEGWQVAB-HUDPDHSWSA-N 179900 US10231963, Table C.4::US10287250, Compound 4::US10736890, Compound TABLE C.4::US10752592, Compound TABLE D.4::US11534436, Compound Table C.4::US9133125, Table D, Compound 4::US9656961, Example 00168 Mu-type opioid receptor Homo sapiens 38.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179900&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86291193 313084727 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944148 COCCN1CC[C@]2(C)[C@@H](C)[C@H]1Cc1ccc(cc21)C(N)=O InChI=1S/C18H26N2O2/c1-12-16-11-13-4-5-14(17(19)21)10-15(13)18(12,2)6-7-20(16)8-9-22-3/h4-5,10,12,16H,6-9,11H2,1-3H3,(H2,19,21)/t12-,16+,18+/m0/s1 SITDOBWLTOMKHJ-BJOOFOGMSA-N 179901 US10231963, Table C.5::US10287250, Compound 14::US10736890, Compound TABLE C.5::US10752592, Compound TABLE D.5::US11534436, Compound Table C.5::US9133125, Table D, Compound 14::US9656961, Example 00169 Mu-type opioid receptor Homo sapiens 0.120 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179901&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582906 313084728 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944149 COCCN1CC[C@]2(C)[C@@H](C)[C@H]1Cc1ccc(cc21)C(N)=O InChI=1S/C18H26N2O2/c1-12-16-11-13-4-5-14(17(19)21)10-15(13)18(12,2)6-7-20(16)8-9-22-3/h4-5,10,12,16H,6-9,11H2,1-3H3,(H2,19,21)/t12-,16+,18+/m0/s1 SITDOBWLTOMKHJ-BJOOFOGMSA-N 179901 US10231963, Table C.5::US10287250, Compound 14::US10736890, Compound TABLE C.5::US10752592, Compound TABLE D.5::US11534436, Compound Table C.5::US9133125, Table D, Compound 14::US9656961, Example 00169 Mu-type opioid receptor Homo sapiens 2.20 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179901&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582906 313084728 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944150 COCCN1CC[C@]2(C)[C@@H](C)[C@H]1Cc1ccc(cc21)C(N)=O InChI=1S/C18H26N2O2/c1-12-16-11-13-4-5-14(17(19)21)10-15(13)18(12,2)6-7-20(16)8-9-22-3/h4-5,10,12,16H,6-9,11H2,1-3H3,(H2,19,21)/t12-,16+,18+/m0/s1 SITDOBWLTOMKHJ-BJOOFOGMSA-N 179901 US10231963, Table C.5::US10287250, Compound 14::US10736890, Compound TABLE C.5::US10752592, Compound TABLE D.5::US11534436, Compound Table C.5::US9133125, Table D, Compound 14::US9656961, Example 00169 Mu-type opioid receptor Homo sapiens 14.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179901&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582906 313084728 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944151 NC(=O)c1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC3CCC3)c2c1 InChI=1S/C22H30N2O/c23-21(25)17-8-7-16-13-20-18-6-1-2-9-22(18,19(16)12-17)10-11-24(20)14-15-4-3-5-15/h7-8,12,15,18,20H,1-6,9-11,13-14H2,(H2,23,25)/t18?,20-,22-/m1/s1 GIZYPGRXWUVSHP-KXBOQVSUSA-N 179902 US10231963, Table C.6::US10287250, Compound D.6::US10736890, Compound TABLE C.6::US10752592, Compound TABLE D.6::US11534436, Compound Table C.6::US9133125, Table D, Compound 6::US9656961, Example 00170 Mu-type opioid receptor Homo sapiens 0.098 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179902&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582147 313084729 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944152 NC(=O)c1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC3CCC3)c2c1 InChI=1S/C22H30N2O/c23-21(25)17-8-7-16-13-20-18-6-1-2-9-22(18,19(16)12-17)10-11-24(20)14-15-4-3-5-15/h7-8,12,15,18,20H,1-6,9-11,13-14H2,(H2,23,25)/t18?,20-,22-/m1/s1 GIZYPGRXWUVSHP-KXBOQVSUSA-N 179902 US10231963, Table C.6::US10287250, Compound D.6::US10736890, Compound TABLE C.6::US10752592, Compound TABLE D.6::US11534436, Compound Table C.6::US9133125, Table D, Compound 6::US9656961, Example 00170 Mu-type opioid receptor Homo sapiens 2.50 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179902&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582147 313084729 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944153 NC(=O)c1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC3CCC3)c2c1 InChI=1S/C22H30N2O/c23-21(25)17-8-7-16-13-20-18-6-1-2-9-22(18,19(16)12-17)10-11-24(20)14-15-4-3-5-15/h7-8,12,15,18,20H,1-6,9-11,13-14H2,(H2,23,25)/t18?,20-,22-/m1/s1 GIZYPGRXWUVSHP-KXBOQVSUSA-N 179902 US10231963, Table C.6::US10287250, Compound D.6::US10736890, Compound TABLE C.6::US10752592, Compound TABLE D.6::US11534436, Compound Table C.6::US9133125, Table D, Compound 6::US9656961, Example 00170 Mu-type opioid receptor Homo sapiens 7.80 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179902&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582147 313084729 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944154 NC(=O)c1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC3CC3)c2c1 InChI=1S/C21H28N2O/c22-20(24)16-7-6-15-12-19-17-3-1-2-8-21(17,18(15)11-16)9-10-23(19)13-14-4-5-14/h6-7,11,14,17,19H,1-5,8-10,12-13H2,(H2,22,24)/t17?,19-,21-/m1/s1 YFSMHTBENRCTNZ-FIALGKLESA-N 179903 US10231963, Table C.7::US10287250, Compound D.7::US10736890, Compound TABLE C.7::US10752592, Compound TABLE D.7::US11534436, Compound Table C.7::US9133125, Table D, Compound 7::US9656961, Example 00171 Mu-type opioid receptor Homo sapiens 0.100 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179903&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582908 313084730 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944155 NC(=O)c1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC3CC3)c2c1 InChI=1S/C21H28N2O/c22-20(24)16-7-6-15-12-19-17-3-1-2-8-21(17,18(15)11-16)9-10-23(19)13-14-4-5-14/h6-7,11,14,17,19H,1-5,8-10,12-13H2,(H2,22,24)/t17?,19-,21-/m1/s1 YFSMHTBENRCTNZ-FIALGKLESA-N 179903 US10231963, Table C.7::US10287250, Compound D.7::US10736890, Compound TABLE C.7::US10752592, Compound TABLE D.7::US11534436, Compound Table C.7::US9133125, Table D, Compound 7::US9656961, Example 00171 Mu-type opioid receptor Homo sapiens 0.890 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179903&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582908 313084730 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944156 NC(=O)c1ccc2C[C@@H]3C4CCCC[C@]4(CCN3CC3CC3)c2c1 InChI=1S/C21H28N2O/c22-20(24)16-7-6-15-12-19-17-3-1-2-8-21(17,18(15)11-16)9-10-23(19)13-14-4-5-14/h6-7,11,14,17,19H,1-5,8-10,12-13H2,(H2,22,24)/t17?,19-,21-/m1/s1 YFSMHTBENRCTNZ-FIALGKLESA-N 179903 US10231963, Table C.7::US10287250, Compound D.7::US10736890, Compound TABLE C.7::US10752592, Compound TABLE D.7::US11534436, Compound Table C.7::US9133125, Table D, Compound 7::US9656961, Example 00171 Mu-type opioid receptor Homo sapiens 1.50 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179903&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 86582908 313084730 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944157 C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@H]1CCCO1)C(N)=O InChI=1S/C20H28N2O2/c1-13-18-11-14-5-6-15(19(21)23)10-17(14)20(13,2)7-8-22(18)12-16-4-3-9-24-16/h5-6,10,13,16,18H,3-4,7-9,11-12H2,1-2H3,(H2,21,23)/t13-,16+,18+,20-/m0/s1 OWRBBFHZDDJXIW-ULPLZVRXSA-N 179904 US10231963, Table C.8::US10287250, Compound D.8::US10736890, Compound TABLE C.8::US10752592, Compound TABLE D.8::US11534436, Compound Table C.8::US9133125, Table D, Compound 8::US9656961, Example 00172 Mu-type opioid receptor Homo sapiens 0.050 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179904&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862230 313084731 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 944158 C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@H]1CCCO1)C(N)=O InChI=1S/C20H28N2O2/c1-13-18-11-14-5-6-15(19(21)23)10-17(14)20(13,2)7-8-22(18)12-16-4-3-9-24-16/h5-6,10,13,16,18H,3-4,7-9,11-12H2,1-2H3,(H2,21,23)/t13-,16+,18+,20-/m0/s1 OWRBBFHZDDJXIW-ULPLZVRXSA-N 179904 US10231963, Table C.8::US10287250, Compound D.8::US10736890, Compound TABLE C.8::US10752592, Compound TABLE D.8::US11534436, Compound Table C.8::US9133125, Table D, Compound 8::US9656961, Example 00172 Mu-type opioid receptor Homo sapiens 58.0 US Patent 10.7270/Q23R0WX0 aid1804706 US10752592 Blumberg, LC; Deaver, DR; Eyerman, DJ; Wynn, TA 8/25/2020 4/11/2021 ALKERMES PHARMA IRELAND LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179904&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 117862230 313084731 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57